About Psychomotor regression-oculomotor apraxia-movement disorder-nephropathy syndrome
Psychomotor regression-oculomotor apraxia-movement disorder-nephropathy syndrome is a rare disease catalogued by Orphanet (ORPHA:505242). It is associated with the SLC30A9 gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Psychomotor regression-oculomotor apraxia-movement disorder-nephropathy syndrome trials.
Search ClinicalTrials.gov for "Psychomotor regression-oculomotor apraxia-movement disorder-nephropathy syndrome" or filter by Orphanet code ORPHA:505242 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Psychomotor regression-oculomotor apraxia-movement disorder-nephropathy syndrome trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Psychomotor regression-oculomotor apraxia-movement disorder-nephropathy syndrome. Updated daily.